Genedata, a Danaher company and a provider of enterprise software solutions for biopharmaceutical R&D, has announced the release of a new Sample Management module as part of its Genedata Biopharma Platform.

The Genedata Biopharma Platform is a prominent platform for discovering and developing novel biotherapeutics, covering the full end-to-end workflow from therapeutics design and engineering to process development, said the company in a statement.

It supports a broad range of therapeutic modalities out of the box, including novel modalities such as multi-specifics, Antibody Drug Conjugates (ADCs), Cell and Gene Therapies, and RNA-LNPs.

Biotherapeutics R&D involves managing a high volume of samples, such as plasmids, cell banks, and purified proteins produced by different groups and stored in freezers or cryobanks at different sites. Sample tracking, often relying on local, decentralised, or home-grown inventory software, is time-consuming, costly, and prone to errors.

Genedata's new Sample Management solution addresses this challenge by offering a dedicated new module for managing the precise physical location of each sample across different groups and sites, down to the building, shelf, and container. This ensures accurate tracking of each sample, enabling compliant and efficient inventory control, sample storage, location, requesting, and distribution. By being directly integrated with the Genedata bioregistration engine, the content and history of all samples are accessible at any time, whether it is a protein, plasmid, cell line, or complex mixture.

What makes this solution unique is its seamless integration within the Genedata Biopharma Platform, including Genedata Biologics and Genedata Bioprocess. This allows sample location data to be automatically linked with all relevant contextual information and metadata such as batch records, molecule properties, genealogy, and assay or QC results. “No other software on the market offers this level of connectivity and information traceability within a single, fully integrated platform. By eliminating the need for external inventory systems, system integration, or data synchronisation, it provides a unified, reliable source of truth for all biological samples,” claimed the company.

It further added that developed in close collaboration with leading biopharma partners, the new module combines robustness with ease of use. It supports configurable inventory hierarchies tailored to diverse laboratory environments, downloadable storage views for collaboration, and container dashboards for placing and retrieving aliquots. Importantly, all sample inventory and ordering processes can be fully automated. With sample quantity tracking capabilities, it adds spatial awareness and operational control to further improve efficiency and reduce risk.

Othmar Pfannes, President of Genedata, said, “Recognising the limitations of existing inventory and sample management solutions, we set out to build a fully integrated module designed to transform laboratory logistics. Our goal is to pave the way for fully automated workflows that bring new levels of efficiency and precision to R&D. With this module, customers can manage their samples and inventories with the same rigour they apply to molecule and cell line registration, ensuring complete traceability for every sample and streamlining the R&D workflow through a trusted central data source.”